Viz.ai

AI that activates care in seconds

San Francisco, CA, US

Viz.ai is a healthcare AI platform that integrates over 50 FDA-cleared AI algorithms to improve clinical workflows and care coordination. It provides solutions for various conditions like stroke, pulmonary embolism, and intracranial hemorrhage, enabling faster diagnosis and treatment. The platform is deployed in nearly 2,000 hospitals across the United States and Europe, serving over 70,000 healthcare provider users.

Shareable draft

Check out Viz.ai on @MedStartr Today Viz.ai is a healthcare AI platform that integrates over 50 FDA-cleared AI algorithms to improve clinical workflows and care coordination. It provides solutions for various conditions like stroke, pulmonary embolism, and intracranial hemorrhage, enabling faster diagnosis and treatment. The platform is deployed in nearly 2,000 hospitals across the United States and Europe, serving over 70,000 healthcare provider users. #LargeVesselOcclusionStroke #IntracranialHemorrhage #SubduralHematoma #AbdominalAorticAneurysm #HypertrophicCardiomyopathy #Osteoporosis #PulmonaryFibrosisInterstitialLungDisease #IschemicStroke #StrokeCerebrovascularDisease #PulmonaryEmbolisms #Aneurysms #CancerOncology #PrecisionMedicineDiagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/xV6Cvu1Q5cU

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in Viz.ai

1 engagement

How We Help

Problem Statement

Clinicians face challenges in efficiently diagnosing and treating conditions like stroke, pulmonary embolism, and intracranial hemorrhage, leading to delays in care coordination and treatment.

Core Technology

AI algorithms, machine learning, clinical decision support, medical imaging analysis

Key Differentiators

Over 50 FDA-cleared AI algorithms; First company awarded CMS reimbursement for AI (stroke module); Extensive peer-reviewed publications (120+); Rapid scan-to-alert delivery (36 seconds); High clinician engagement (90% click-through rate)

Clinical Focus

Emergency Medicine; Neurology; Cardiology; Pulmonology; Oncology; Radiology

Company Info

Business Model: B2B SaaS
Founded: 2016
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now

Disease Areas

Large Vessel Occlusion Stroke Intracranial Hemorrhage Subdural Hematoma Abdominal Aortic Aneurysm Hypertrophic Cardiomyopathy Osteoporosis Pulmonary Fibrosis & Interstitial Lung Disease Ischemic Stroke Stroke & Cerebrovascular Disease Pulmonary Embolisms Aneurysms Cancer & Oncology

Technologies

Machine LearningMedical ImagingClinical WorkflowAutonomous AI AgentsAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

50+ FDA 510(k) clearances; first De Novo approval for hypertrophic cardiomyopathy detection; peer-reviewed studies demonstrating 31-minute reduction in door-to-treatment time and improved reperfusion rates

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Viz.ai?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.